Kamada (KMDA) Interest & Investment Income (2012 - 2026)
Kamada (KMDA) reported Interest & Investment Income of $425000.0 for Q1 2026, down 20.41% on a YoY basis from $534000.0 in Q1 2025, and down 77.88% quarter-over-quarter from $1.9 million in Q4 2025.
Kamada (KMDA) Interest & Investment Income (2012 - 2026) Analysis & Trends
Kamada has reported Interest & Investment Income for 15 years, with the latest figure at $425000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 20.41% year-over-year to $425000.0; the trailing twelve-month figure through Mar 2026 stood at $425000.0 (down 20.41% YoY), and the FY2025 full-year result was $1.9 million, down 9.3% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $425000.0, down from $1.9 million in the prior quarter.
- The five-year high for Interest & Investment Income was $2.1 million in Q4 2024, with the low at $25.0 in Q1 2023.
- Historically, Interest & Investment Income has averaged $554322.1 across 5 years, with a median of $92000.0 in 2023.
- Annual changes were most pronounced in 2022 — Interest & Investment Income sank 99.99% — and 2024, when it soared 1119900.0%.
- Kamada's Interest & Investment Income stood at $32.0 in 2022, then soared by 287400.0% to $92000.0 in 2023, then jumped by 2202.17% to $2.1 million in 2024, then declined by 9.3% to $1.9 million in 2025, then slumped by 77.88% to $425000.0 in 2026.
- The last three Interest & Investment Income figures came in at $425000.0 (Q1 2026), $1.9 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Kamada | 506.10 | -73.15 Mn | 19.12 Mn | 425,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 425,000.00 |
| Dec 31, 2025 | 1.92 Mn |
| Sep 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 987.00 |
| Mar 31, 2025 | 534,000.00 |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 788.00 |
| Mar 31, 2024 | 280,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | 25.00 |
| Sep 30, 2022 | 32.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Sep 30, 2021 | 277,000.00 |
| Jun 30, 2021 | 209,000.00 |
| Mar 31, 2021 | 110,000.00 |
| Dec 31, 2020 | 1.03 Mn |
| Sep 30, 2020 | 865,000.00 |